and by Morrison, Hall and Chaney (1948) who noted a greater tendency to hypercholesterolaemia among patients with coronary disease below the age of sixty than among older patients. A similar tendency was noted by Collen (1949) and by Geier (1949) ; this last author states that whereas none of 16 healthy subjects had a plasma cholesterol concentration exceeding 300 mg. per 100 ml., this level was exceeded by 43 per cent, of patients with coronary artery disease and under fifty-five years old, but by only 16 per cent, of similar patients over fifty-five years old. These results, which form a fair cross section of those reported in the literature, show that hypercholesterolaemia, in the sense of a plasma cholesterol concentration distinctly above the normal maximum, does not necessarily precede coronary artery disease. However, the normal range is so wide that the figure found in a patient with coronary arteriosclerosis may well represent a personal hypercholesterolaemia? i.e. be above that previously customary for the individual concerned. It is, however, striking that such tendency to hypercholesterolaemia (in the general sense) as exists is greater in the younger patients.
Histological examination of normal, atheromatous and sclerotic arteries shows that deposition of cholesterol in the vessel walls is an important part of the disease process (Virchow, 1924 ; Aschoff, 1924 ;  and Leary, 1944) .
A similar conclusion is given by the animal experiments of Anitschow (1924) , Weinhouse and Hirsch (1940) , Leary (1941) , Mukherjee (1948) and others. However, although it would appear that hypercholesterolemia may aid abnormal deposition of cholesterol in vessel walls, it has not been shown to be an essential factor, and, indeed, Duff (1935) claimed to have observed that injury to the vessels seemed to precede the deposition of cholesterol.
On the whole, it appears likely, as Peters and Van Slyke (1946) (2) of finding, by determining both free and total cholesterol, whether other metabolic disturbances in the liver might be implicated ; (3) of investigating similarly the plasma cholesterol in groups of patients of ages comparable to those with coronary disease but suffering from other abnormalities, some of which could be expected to involve arterial degeneration.
Methods
Total cholesterol was determined in plasma separated from oxalated venous blood withdrawn (in the case of the hospital patients) at io-n a.m., about three hours after breakfast. The method used was that of Sackett (1925) adapted for use with a Spekker absorptiometer.
Free cholesterol was determined in the same plasma samples by Clarke and Marney's (1945) modification of the digitonin precipitation method described by Schoenheimer and Sperry (1934) .
This combination of methods was chosen as being more convenient than using the digitonin method before and after hydrolysis. That it is reliable is indicated by the fact that the ratio of free to total cholesterol obtained by its use agrees well with the ratio reported by other methods.
Normal Controls
As normal controls, blood was obtained from 50 healthy subjects (blood donors) within the age range of twenty to sixty, and including both men and women, between whom there seems to be no significant difference in plasma cholesterol level (Kounts, Sonnenberg, Hofstatter and Wolff, 1945) . The blood was withdrawn during the afternoon, two to three hours after a light lunch.
The mean values, ranges, and standard deviations are given in Table I . The standard deviations are not strictly accurate since the distribution curve is slightly skew. The range in our series was smaller than some previously reported (e.g. Peters and Man (1943) The free cholesterol concentration in the series reported here agrees well, both as regards absolute value and ratio to total cholesterol with that reported by Sperry (1936) and by Peters and Man (1943) . As in their series the range of variation was very small?much less than has been reported by certain other earlier workers.
Results in Recent Coronary Infarction
The subjects were 52 patients (50 males and 2 females) aged between forty-two and seventy-two who had been admitted to hospital because of coronary infarction. The blood for examination was withdrawn, in every case, within twenty-four hours of the attack, and usually before the administration of any anti-coagulant drug. The diagnosis was in all cases confirmed by clinical and electrocardiographic examination.
The data are summarised in Table II . The means and standard deviations are such as to suggest no clearly significant differences from the normal controls. Nevertheless, there is a tendency for the coronary infarction patients to have slightly higher plasma cholesterol levels (both total and free) than the normal subjects. This tendencyis shown for total cholesterol in the distribution diagram (Fig. 1 a) (B) , and the ratio (C) in cases of acute coronary infarction (black columns), and in healthy subjects (white columns). The total plasma cholesterol (A), the free cholesterol (B), and the ratio (C) in cases of acute coronary infarction (black columns), and in healthy subjects (white columns).
The mean proportion of the total cholesterol existing in the free state is nearly the same for the two groups of subjects, but among the coronary infarction patients the range is rather greater (Fig. i^r Moreover, analysis of the 52 cases of acute coronary infarction supports the conclusion that the occurrence of anginal pain is a more important factor in relation to hypercholesterolemia than the actual coronary infarction.
Of these cases, 12 gave a history of previous attacks of pain ; the total plasma cholesterol ranged from 250-305 mg.
per 100 ml., with a mean of 269*5.
The free cholesterol concentration in the plasma showed a similar general, and indeed proportional, increase above the normal ; the ratio of free cholesterol to total cholesterol was consequently unchanged from that shown in the normal controls. (B) , and the ratio (C) in hypertensive subjects (black columns), compared with healthy subjects (white columns).
in whom the hypertension is of relatively short duration, but it must be emphasised that this tendency has not been shown to be statistically of patients with congestive heart failure. In these there is a similar disturbance which could well lead to a similar apparent diminution in liver functional efficiency and indeed, the condition of " cardiac cirrhosis " has been described as a late phenomenon in recurrent congestive heart failure.
The relevant data from 13 cases are summarised in Table IX. There is an obvious diminution in the total plasma cholesterol during the acute phase of congestive failure and, since the free plasma cholesterol is not similarly reduced, the abnormality consists in a reduction of the combined cholesterol.
This, of course, gives an F apparent increase in Xioo, such as is commonly found associated with liver disease. The clinical examination of the patients during this phase showed a rough correlation between the degree of liver F enlargement and the abnormality of X 100, but none between this abnormality and the number of previous attacks.
After clinical recovery the same patients were re-examined. Those who had had not more than two previous attacks of congestive heart failure showed an increase in the total plasma cholesterol to the normal F level with a return of Xioo to normal. In these patients the liver had returned to normal size and the cephalin cholesterol test gave a negative result. The patients with several previous episodes showed a much smaller increase in the total plasma cholesterol, a continuing high These results strongly suggest that the circulatory failure in these patients produces impairment of the hepatic functional efficiency and that long continuation or repetition of the condition leads ultimately to cellular damage. It cannot be concluded definitely that the similar derangement of the plasma cholesterol associated with hypertension and with coronary disease is also due to liver inefficiency. Since, however, these other conditions involve vascular changes which must be expected to affect the liver in the same way as does congestive heart failure, the conclusion is at least probable that liver inefficiency plays a part.
Discussion
This suggestion, that vascular degenerative changes slowly produce some abnormality of cholesterol metabolism is strengthened by the finding that in angina pectoris the tendency to hypercholesterolemia is roughly proportional to the period over which anginal pains have been observed, and that, in the same subjects there is a rough parallelism between the plasma cholesterol and the blood pressure. Anrep, Davis and Volhard (1931) , Gregg (1934) , Johnson and Di Palma (i939)> Moschkowitz (1942) and others to develop the theory that atheromatous change is the result of excessive localised intravascular pressure.
The actual production of thrombi may be attributed to some abnormality of the clotting mechanism which is potentiated by the local injury to the artery wall (although it is not clear whether such a clotting abnormality must necessarily be postulated). It is fairly well established (Wright, 1948) that the mast cells of the liver and the walls of the smaller blood vessels produce heparin ; others {e.g. Jorpes, Holmgren and Wilander, 1937 ;  Levene and Lopez-Suarez, 1918) have extracted a heparin-like substance from the wall of the aorta, and Faber (1946, 1949) (Hawkins, 1934 ; Cantarrow, 1935 ; Epstein, 1936) , in which, as we have found, repeated failures may lead to a deficiency demonstrable in other ways?<? cardiac cirrhosis." There is a strong suggestion that the abnormality of the plasma cholesterol in hypertension, whilst in part due to the causes which produce vascular degeneration, is partly the result of " hypertensive liver deficiency "?a supply lack in the earlier stages which, as in congestive heart failure, may lead ultimately to actual cellular damage.
It is, however, clear that on the evidence presented the abnormalities of the plasma cholesterol in angina pectoris, in hypertension and in congestive heart failure cannot all be ascribed solely to the effect of hepatic deficiency. For whereas in the first two of these conditions there is a slight tendency for the total cholesterol to be raised and a more marked tendency for the free cholesterol to be increased with a consequential change in the ratio, congestive heart failure is characterised by a decrease in the total cholesterol with no change 5. Patients with congestive heart failure showed a marked diminution in the total plasma cholesterol with return to normal levels on recovery except in those patients who had suffered several previous acute attacks. The free cholesterol was not similarly reduced, so that P ^Xioo was high. These changes were roughly correlated with the duration of the condition and with evidence of hepatic functional impairment.
6. It is suggested that degenerative changes in the vascular system slowly produce abnormalities in the cholesterol level of the plasma partly by interference with the functional efficiency of the liver and partly by interference with the supply of heparin from the mast cells which, normally present in the wall of the aorta and of the coronary artery were found to be absent from these sites in 3 cases with atheromatous changes.
